by Iga VonGeyso | Feb 5, 2024 | Article
Artificial Intelligence (AI) has existed since the 1950s1 but exploded in recent popularity as generative/conversational AI enables users to create written and visual content, flooding the educational and creative worlds with new capabilities but also placing the...
by Iga VonGeyso | Dec 20, 2023 | Case Study
We support our clients by facilitating the development and maintenance of relevant data, employing modern analytic applications, and building scalable, automated processes. Client Situation Pharmacies face pressure from PBMs, health plans, and other third-party...
by Iga VonGeyso | Dec 18, 2023 | Article
The Inflation Reduction Act of 2022 triggered a flurry of Congressional bills to curb rising drug prices. The Congressional Budget Office (CBO) noted that the increased utilization of generics was not enough to offset the rising prices of brand drugs in recent years...
by Iga VonGeyso | Dec 18, 2023 | Article
Ozempic, Mounjaro, and Wegovy are some of the explosively popular GLP-1 drugs making headlines in 2023. GLP-1 stands for Glucagon-like Peptide-1, a hormone released during eating that prompts insulin production and increases feelings of satiety. GLP-1 Receptor...
by Iga VonGeyso | Nov 21, 2023 | Case Study
We assist our clients by simplifying their network management methods and intricate data structures through centralizing contract attributes and creating versatile data sets. Client Situation PBMs experience constant change throughout the year, including...